| Literature DB >> 28203205 |
Ian B Stewart1, Brittany Dias1, David N Borg1, Aaron J E Bach1, Beatrix Feigl2, Joseph T Costello3.
Abstract
Current hydration assessments involve biological fluids that are either compromised in dehydrated individuals or require laboratory equipment, making timely results unfeasible. The eye has been proposed as a potential site to provide a field-based hydration measure. The present study evaluated the efficacy and sensitivity of intraocular pressure (IOP) to assess hydration status. Twelve healthy males undertook two 150 min walking trials in 40°C 20% relative humidity. One trial matched fluid intake to body mass loss (control, CON) and the other had fluid restricted (dehydrated, DEH). IOP (rebound tonometry) and hydration status (nude body mass and serum osmolality) were determined every 30 min. Body mass and serum osmolality were significantly (p < 0.05) different between trials at all-time points following baseline. Body mass losses reached 2.5 ± 0.2% and serum osmolality 299 ± 5 mOsmol.kg-1 in DEH. A significant trial by time interaction was observed for IOP (p = 0.042), indicating that over the duration of the trials IOP declined to a greater extent in the DEH compared with the CON trial. Compared with baseline measurements IOP was reduced during DEH (150 min: -2.7 ± 1.9 mm Hg; p < 0.05) but remained stable in CON (150 min: -0.3 ± 2.4 mm Hg). However, using an IOP value of 13.2 mm Hg to predict a 2% body mass loss resulted in only 57% of the data being correctly classified (sensitivity 55% and specificity 57%). The use of ΔIOP (-2.4 mm Hg) marginally improved the predictive ability with 77% of the data correctly classified (sensitivity: 55%; specificity: 81%). The present study provides evidence that the large inter-individual variability in baseline IOP and in the IOP response to progressive dehydration, prevents the use of IOP as an acute single assessment marker of hydration status.Entities:
Keywords: dehydration; exercise; eye; heat; hydration assessment; intraocular pressure
Year: 2017 PMID: 28203205 PMCID: PMC5285388 DOI: 10.3389/fphys.2017.00036
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Physiological changes observed during the fluid restriction (DEH) and provision (CON) trials.
| CON | 14.4 ± 4.1 | 15.5 ± 3.9 | 14.7 ± 3.9 | 14.1 ± 4.0 | 14.5 ± 3.5 | 14.2 ± 4.0 |
| DEH | 15.6 ± 3.5 | 14.2 ± 3.5 | 14.8 ± 4.1 | 13.3 ± 3.3 | 13.2 ± 3.6 | 13.0 ± 3.0 |
| CON | 0.0 ± 0.1 | −0.1 ± 0.1 | −0.1 ± 0.1 | −0.1 ± 0.2 | −0.2 ± 0.2 | |
| DEH | −0.5 ± 0.1 | −1.0 ± 0.1 | −1.5 ± 0.1 | −2.0 ± 0.2 | −2.5 ± 0.2 | |
| CON | 291 ± 5 | 291 ± 3 | 291 ± 4 | 291 ± 3 | 292 ± 4 | 292 ± 3 |
| DEH | 292 ± 3 | 293 ± 3 | 294 ± 3 | 297 ± 4 | 298 ± 4 | 299 ± 5 |
| CON | 37.2 ± 0.3 | 37.4 ± 0.2 | 37.5 ± 0.2 | 37.6 ± 0.2 | 37.6 ± 0.2 | 37.6 ± 0.2 |
| DEH | 37.1 ± 0.3 | 37.4 ± 0.2 | 37.6 ± 0.2 | 37.7 ± 0.2 | 37.9 ± 0.2 | 38.0 ± 0.2 |
| CON | 68 ± 7 | 72 ± 12 | 74 ± 12 | 78 ± 13 | 78 ± 12 | 79 ± 13 |
| DEH | 66 ± 9 | 74 ± 16 | 77 ± 16 | 83 ± 17 | 89 ± 18 | 96 ± 19 |
| CON | 89 ± 8 | 88 ± 8 | 88 ± 6 | 88 ± 5 | 88 ± 6 | 89 ± 6 |
| DEH | 90 ± 6 | 91 ± 6 | 91 ± 8 | 90 ± 7 | 91 ± 7 | 89 ± 9 |
| CON | 1.03 ± 0.46 | 0.98 ± 0.44 | 0.73 ± 0.47 | 0.93 ± 0.54 | 0.77 ± 0.41 | 0.94 ± 0.56 |
| DEH | 1.31 ± 0.74 | 0.92 ± 0.49 | 0.89 ± 0.57 | 1.16 ± 1.06 | 1.09 ± 0.85 | 1.20 ± 0.81 |
Data are mean ± SD (n = 12). Significantly different to control at same time point
(p < 0.05);
(p < 0.001).
Univariate general linear model for IOP, Δ IOP, and covariates, with participant ID as a random factor.
| Δ Body mass | 22.096 | 1, 107 | <0.001 | 14.75 (1.164) | 0.77 | 0.41 | 1.13 |
| Blood pressure | 0.552 | 1, 131 | 0.459 | 4.91 (3.92) | 0.03 | −0.05 | 0.01 |
| Blood lactate | 0.004 | 1, 129 | 0.952 | 14.29 (1.01) | 0.02 | −0.66 | 0.70 |
| Δ Body mass | 56.352 | 1, 107 | <0.001 | 0.26 (0.88) | 1.33 | 0.94 | 1.72 |
| Serum osmolality | 62.920 | 1, 106 | <0.001 | 94 (41) | −323 | −412 | −233 |
| Core temperature | 22.976 | 1, 101 | <0.001 | 127.78 (1.58) | −3.42 | −4.99 | −1.85 |
Only data at 30, 60, 90, 120, and 150 min time points was used in this analysis as baseline values were “0” for all participants.
SE–standard error of intercept.
95% CI–95% confidence interval around the slope of the line.
Figure 1(A) Sensitivity and specificity capability of IOP using a 13.2 mm Hg criterion value to assess a 2% body mass loss. Dashed lines represent −2% body mass change and 13.2 mm Hg IOP. (B) Sensitivity and specificity capability of a ΔIOP using a −2.4 mm Hg criterion value to assess a 2% body mass loss. Dashed lines represent −2% body mass change and −2.4 mm Hg IOP. Solid circles represent correct classification (true positive and negative) and open circles incorrect classification (false positive and negative).
Figure 2ΔIOP from baseline in the fluid restriction (DEH) and provision (CON) trials. Significantly different to control at same time point *p < 0.05.